Clinical Trial Update: Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of letrozole during the luteal phase after controlled ovarian stimulation in oocyte donors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Luteinised Follicular Cyst

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: IVI Madrid | Conditions: Luteinised Follicular Cyst | Phase 3 | Status: RECRUITING